Physician profile
Todd E Fowler
NPI 1164468674
$861.52
in general payments reported to CMS, 2019-2025
10 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.40 · 2021: $30.37 · 2022: $104 · 2023: $85.66 · 2024: $141 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $247.62 | 2022-2025 | Stealthstation S8 Platform, Microstream |
| Regeneron Healthcare Solutions, INC. | $236.82 | 2024-2025 | Libtayo, Dupixent |
| Inspire Medical Systems, INC. | $96.13 | 2024-2025 | Inspire |
| Genzyme Corporation | $84.65 | 2023-2025 | |
| Stryker Corporation | $65.56 | 2019-2023 | Clarifix Cryotherapy Device |
| Glaxosmithkline, LLC. | $45.03 | 2023 | Nucala |
| Intersect Ent, INC. | $31.37 | 2019-2021 | |
| Kerecis Limited | $24.43 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Merck Sharp & Dohme LLC | $15.61 | 2021 | |
| Hikma Pharmaceuticals USA | $14.30 | 2025 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.